Skip to main content
SpringerLink
Log in

Treatment of Aphthous Stomatitis with Topical Alchemilla vulgaris in Glycerine

  • Original Research Article
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Background and objective: Recurrent aphthous ulceration is the most common oral mucosal disease known. It presents as three types: minor (most prevalent), major and herpetiform. However, there are no well established effective and reliable treatments of this condition. Alchemilla vulgaris (Lady’s Mantle) has traditionally been used in oral hygiene and was recently shown to accelerate wound healing when used in combination with glycerine. The objective of this study was to determine whether this combination is effective in the treatment of the most prevalent form of aphthous ulcers.

Methods: An open-label study was conducted in 48 otherwise healthy male and female patients aged 4–44 years to determine the putative healing properties and tolerability of a standard 3% extract of A. vulgaris in glycerine (Aphtarine®) on common minor oral ulcers. Patients with major or herpetiform ulcers were excluded from the study.

Results: Topical application three times daily of Aphtarine® gel to minor mouth ulcers relieved discomfort and produced complete healing in the majority of patients (60.4%) within 2 days and in 75% within 3 days, compared with 10.4% and 33.3%, respectively, without treatment and 15% and 40%, respectively, with commonly available treatments. Most patients appreciated the product’s ease of application, taste and texture. Aphtarine® was well tolerated locally and most patients rated the product good to excellent overall.

Conclusion: Aphtarine® is a safe, well tolerated and highly effective promising new treatment for healing common mouth ulcers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I

Similar content being viewed by others

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Ship JA. Recurrent aphthous stomatitis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81(2): 141–7

    Article  PubMed  CAS  Google Scholar 

  2. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm 2001; 58(1): 41–50

    PubMed  CAS  Google Scholar 

  3. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis 2001; 68(3): 201–6

    PubMed  CAS  Google Scholar 

  4. Kerr AR, Ship JA. Management strategies for HIV-associated aphthous stomatitis. Am J Clin Dermatol 2003; 4(10): 669–80

    Article  PubMed  Google Scholar 

  5. Natah SS, Konttinen YT, Enattah NS, et al. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 2004; 33(3): 221–34

    Article  PubMed  CAS  Google Scholar 

  6. Woo SB, Sonis ST. Recurrent aphthous ulcers: a review of diagnosis and treatment. J Am Dent Assoc 1996; 127(8): 1202–13

    PubMed  CAS  Google Scholar 

  7. Jurge S, Kuffer R, Scully C, et al. Recurrent aphthous stomatitis. Oral Dis 2006; 12(1): 1–21

    Article  PubMed  CAS  Google Scholar 

  8. McBride DR. Management of aphthous ulcers. Am Fam Physician 2000; 62(1): 149–54, 160

    PubMed  CAS  Google Scholar 

  9. Burgess JA, Johnson BD, Sommers E. Pharmacological management of recurrent oral mucosal ulceration. Drugs 1990; 39(1): 54–65

    Article  PubMed  CAS  Google Scholar 

  10. Rees TD, Binnie WH. Recurrent aphthous stomatitis. Dermatol Clin 1996; 14(2): 243–56

    Article  PubMed  CAS  Google Scholar 

  11. Scully C, Shotts R. Mouth ulcers and other causes of orofacial soreness and pain. BMJ 2000; 321(7254): 162–5

    Article  PubMed  CAS  Google Scholar 

  12. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am 2005;49(1): 31–47

    Article  PubMed  Google Scholar 

  13. Ship JA, Chavez EM, Doerr PA, et al. Recurrent aphthous stomatitis. Quintessence Int 2000; 31(2): 95–112

    PubMed  CAS  Google Scholar 

  14. Lesclous P, Molko S, Samson J. Aphtes et aphtose buccopharynges. Les Cahiers de l’Assoc Dentaire Francais 2000; 10: 5–9

    Google Scholar 

  15. Shrivastava R. Non-solid composition for local application. Patent PCT/FR/99/01340. 1999

  16. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341(10): 738–46

    Article  PubMed  CAS  Google Scholar 

  17. van Baare J, Ligtvoet EE, Middelkoop E. Microbiological evaluation of glycerolized cadaveric donor skin. Transplantation 1998; 65(7): 966–70

    Article  PubMed  Google Scholar 

  18. Smith JL, Bencivengo MM, Kunsch CA. Enterotoxin A synthesis in Staphylococcus aureus: inhibition by glycerol and maltose. J Gen Microbiol 1986; 132(12): 3375–80

    PubMed  CAS  Google Scholar 

  19. Svanberg M, Birkhed D. Effect of dentifrices containing either xylitol and glycerol or sorbitol on mutans streptococci in saliva. Caries Res 1991; 25(6): 449–53

    Article  PubMed  CAS  Google Scholar 

  20. Lu HF, Tsou MF, Lin JG, et al. Ellagic acid inhibits growth and arylamine N-acetyltransferase activity and gene expression in Staphylococcus aureus. In Vivo 2005; 19(1): 195–9

    PubMed  CAS  Google Scholar 

  21. Akiyama H, Fujii K, Yamasaki O, et al. Antibacterial action of several tannins against Staphylococcus aureus. J Antimicrob Chemother 2001; 48(4): 487–91

    Article  PubMed  CAS  Google Scholar 

  22. Fraisse D, Carnat A, Carnat AP, et al. Standardization of the aerial parts of Alchemilla. Ann Pharm Fr 1999; 57(5): 401–5

    PubMed  CAS  Google Scholar 

  23. Jonadet M, Meunier MT, Villie F, et al. Flavonoids extracted from Ribes nigrum L. and Alchemilla vulgaris L: 1. In vitro inhibitory activities on elastase, trypsin and chymotrypsin. 2. Angioprotective activities compared in vivo. J Pharmacol 1986; 17(1): 21–7

    PubMed  CAS  Google Scholar 

  24. Lamaison JL, Carnat A, Petitjean-Freytet C. Tannin content and inhibiting activity of elastase in Rosaceae. Ann Pharm Fr 1990; 48(6): 335–40

    PubMed  CAS  Google Scholar 

  25. Lamaison JL, Carnat A, Petitjean-Freytet C, et al. Quercetin-3-glucuronide, main flavonoid of Alchemilla, Alchemilla xanthochlora Rothm. (Rosaceae). Ann Pharm Fr 1991; 49(4): 186–9

    PubMed  CAS  Google Scholar 

  26. Heikel H. Contribution to the study of Alchemilla vulgaris [thesis]. Lyon,France: Claude Bernard University, 1995: 1–106

    Google Scholar 

  27. Jimenez F, Mitts TF, Liu K, et al. Ellagic and tannic acids protect newly synthesized elastic fibers from premature enzymatic degradation in dermal fibroblast cultures. J Invest Dermatol 2006; 126(6): 1272–80

    Article  PubMed  CAS  Google Scholar 

  28. Ashoori F, Suzuki S, Zhou JH, et al. Involvement of lipid peroxidation in necrosis of skin flaps and its suppression by ellagic acid. Plast Reconstr Surg 1994; 94(7): 1027–37

    Article  PubMed  CAS  Google Scholar 

  29. Murthy KN, Reddy VK, Veigas JM, et al. Study on wound healing activity of Punica granatum peel. J Med Food 2004; 7(2): 256–9

    Article  PubMed  CAS  Google Scholar 

  30. Morikawa K, Nonaka M, Narahara M, et al. Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sci 2003; 74(6): 709–21

    Article  PubMed  CAS  Google Scholar 

  31. Rotelli AE, Guardia T, Juarez AO, et al. Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 2003; 48(6): 601–6

    Article  PubMed  CAS  Google Scholar 

  32. Gomathi K, Gopinath D, Rafiuddin Ahmed M, et al. Quercetin incorporated collagen matrices for dermal wound healing processes in rat. Biomaterials 2003; 24(16): 2767–72

    Article  PubMed  CAS  Google Scholar 

  33. Skaper SD, Fabris M, Ferrari V, et al. Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med 1997; 22(4): 669–78

    Article  PubMed  CAS  Google Scholar 

  34. Gutierrez-Venegas G, Kawasaki-Cardenas P, Rita Arroyo-Cruz S, et al. Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. Eur J Pharmacol 2006; 541: 95–105

    Article  PubMed  CAS  Google Scholar 

  35. Hougee S, Sanders A, Faber J, et al. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem Pharmacol 2005; 69(2): 241–8

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was sponsored by the Naturveda — Vitro-Bio Research Institute. The authors are employees of this institute.

Author information

Authors and Affiliations

  1. Naturveda - Vitro-Bio Research Institute, ZAC de Lavaur, 63500, Issoire, France

    Ravi Shrivastava & Gareth W. John

Authors
  1. Ravi Shrivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gareth W. John
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ravi Shrivastava.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shrivastava, R., John, G.W. Treatment of Aphthous Stomatitis with Topical Alchemilla vulgaris in Glycerine. Clin. Drug Investig. 26, 567–573 (2006). https://doi.org/10.2165/00044011-200626100-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200626100-00003

Keywords

Search

Navigation